Literature DB >> 25523949

Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C δ in human neuroblastoma dopaminergic SH-SY5Y cell lines.

Yunsung Nam1, Myung Bok Wie2, Eun-Joo Shin1, Thuy-Ty Lan Nguyen1, Seung-Yeol Nah3, Sung Kwon Ko4, Ji Hoon Jeong5, Choon-Gon Jang6, Hyoung-Chun Kim1.   

Abstract

Recently, we have demonstrated that ginsenoside Re protects methamphetamine (MA)-induced dopaminergic toxicity in mice via genetic inhibition of PKCδ and attenuation of mitochondrial stress. In addition, we have reported that induction of mitochondrial glutathione peroxidase (GPx) is also important for neuroprotection mediated by ginsenoside Re. To extend our knowledge, we examined the effects of ginsenoside Re against MA toxicity in vitro condition using SH-SY5Y neuroblastoma cells. Treatment with ginsenoside Re resulted in significant attenuations against a decrease in the activity of GPx and an increase in the activity of superoxide dismutase (SOD) in the cytosolic and mitochondrial fraction. The changes in glutathione (GSH) paralleled those in GPx in the same experimental condition. Consistently, ginsenoside Re treatment exhibited significant protections against cytosolic and mitochondrial oxidative damage (i.e. lipid peroxidation and protein oxidation), mitochondrial translocation of PKCδ, mitochondrial dysfunction (mitochondrial transmembrane potential and intra-mitochondrial Ca(2+)), apoptotic events [i.e., cytochrome c release from mitochondria, cleavage of caspase-3 and poly(ADP-ribose)polymerase-1, nuclear condensation, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL)-positive apoptotic cells], and a reduction in the tyrosine hydroxylase (TH) expression and TH activity induced by MA in SH-SY5Y neuroblastoma cells. These protective effects of ginsenoside Re were comparable to those of PKCδ antisense oligonucleotide (ASO). However, ginsenoside Re did not significantly provide additional protective effects mediated by genetic inhibition of PKCδ. Our results suggest that PKCδ is a specific target for ginsenoside Re-mediated protective activity against MA toxicity in SH-SY5Y neuroblastoma cells.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  apoptosis; ginsenoside Re; glutathione; glutathione peroxidase; methamphetamine; mitochondria; oxidative damage; tyrosine hydroxylase

Mesh:

Substances:

Year:  2014        PMID: 25523949     DOI: 10.1002/jat.3093

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  21 in total

Review 1.  Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis-A Review.

Authors:  Eun-Joo Shin; Hai-Quyen Tran; Phuong-Tram Nguyen; Ji Hoon Jeong; Seung-Yeol Nah; Choon-Gon Jang; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Res       Date:  2017-06-07       Impact factor: 3.996

Review 2.  Role of Protein Kinase C in Bipolar Disorder: A Review of the Current Literature.

Authors:  Ashwini Saxena; Giselli Scaini; Daniela V Bavaresco; Camila Leite; Samira S Valvassori; André F Carvalho; João Quevedo
Journal:  Mol Neuropsychiatry       Date:  2017-10-07

3.  Exposure to Far Infrared Ray Protects Methamphetamine-Induced Behavioral Sensitization in Glutathione Peroxidase-1 Knockout Mice via Attenuating Mitochondrial Burdens and Dopamine D1 Receptor Activation.

Authors:  Huynh Nhu Mai; Naveen Sharma; Eun-Joo Shin; Bao Trong Nguyen; Ji Hoon Jeong; Choon-Gon Jang; Eun-Hee Cho; Seung Yeol Nah; Nam Hun Kim; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Res       Date:  2018-04-23       Impact factor: 3.996

Review 4.  Intracellular Signaling Cascades in Bipolar Disorder.

Authors:  Gregory H Jones; Carola Rong; Aisha S Shariq; Abhinav Mishra; Rodrigo Machado-Vieira
Journal:  Curr Top Behav Neurosci       Date:  2021

5.  N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change.

Authors:  Eun-Joo Shin; Yunsung Nam; Ji Won Lee; Phuong-Khue Thi Nguyen; Ji Eun Yoo; The-Vinh Tran; Ji Hoon Jeong; Choon-Gon Jang; Young J Oh; Moussa B H Youdim; Phil Ho Lee; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Mol Neurobiol       Date:  2015-11-13       Impact factor: 5.590

Review 6.  Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease.

Authors:  Eun-Joo Shin; Ji Hoon Jeong; Yeonggwang Hwang; Naveen Sharma; Duy-Khanh Dang; Bao-Trong Nguyen; Seung-Yeol Nah; Choon-Gon Jang; Guoying Bing; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Arch Pharm Res       Date:  2021-07-20       Impact factor: 4.946

7.  Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK.

Authors:  Duy-Khanh Dang; Eun-Joo Shin; Yunsung Nam; Sungwoo Ryoo; Ji Hoon Jeong; Choon-Gon Jang; Toshitaka Nabeshima; Jau-Shyong Hong; Hyoung-Chun Kim
Journal:  J Neuroinflammation       Date:  2016-01-18       Impact factor: 8.322

Review 8.  The Role of Chinese Herbal Therapy in Methamphetamine Abuse and its Induced Psychiatric Symptoms.

Authors:  Lin Chen; Qin Ru; Qi Xiong; Mei Zhou; Kai Yue; Yuxiang Wu
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

9.  Ginsenoside Re Protects against Serotonergic Behaviors Evoked by 2,5-Dimethoxy-4-iodo-amphetamine in Mice via Inhibition of PKCδ-Mediated Mitochondrial Dysfunction.

Authors:  Eun-Joo Shin; Ji Hoon Jeong; Bao-Trong Nguyen; Naveen Sharma; Seung-Yeol Nah; Yoon Hee Chung; Yi Lee; Jae Kyung Byun; Toshitaka Nabeshima; Sung Kwon Ko; Hyoung-Chun Kim
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

Review 10.  Neurotoxicity of methamphetamine: Main effects and mechanisms.

Authors:  Subramaniam Jayanthi; Atul P Daiwile; Jean Lud Cadet
Journal:  Exp Neurol       Date:  2021-06-26       Impact factor: 5.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.